← Back to Clinical Trials
Recruiting NCT06313866

the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI

Trial Parameters

Condition Stroke
Sponsor Hangzhou Medical College
Study Type INTERVENTIONAL
Phase N/A
Enrollment 220
Sex ALL
Min Age N/A
Max Age 70 Years
Start Date 2024-04-01
Completion 2025-04-01
Interventions
controlElectronuchal acupuncture group treatmentSmell therapy group treatment

Brief Summary

The patients with cognitive impairment after stroke were divided into control group, electroacupuncture group, olfactory therapy group, electroacupuncture combined with olfactory therapy group, and sham group with 35 people in each group. After the end of the treatment, the clinical efficacy was evaluated.

Eligibility Criteria

Inclusion Criteria: * (1) Stroke as per the TCM definition, presenting symptoms include unilateral paresis or paralysis, sensory deficits, speech impairment, and hemianopsia. PSCI diagnosis involves clinically significant deficits in at least one cognitive domain and severe disruption of instrumental ADLs/ADLs.; (2) The scores on the MMSE scale must adhere to the following criteria: Less than 17 points for individuals with illiteracy, less than 20 points for those with primary school education, and less than 24 points for individuals with a middle school education or higher.; (3) Aged under 70 years; (4) No history of mental illness, clear consciousness, stable vital signs, and able to complete the scale assessment; (5) Within 6 months post-stroke, diagnosed as a patient in the recovery period of cerebral infarction (or cerebral hemorrhage) at admission; (6) Signed informed consent by the patient or their family. Exclusion Criteria: * (1) Transient ischemic attack; (2) Subarachnoid hem

Related Trials